387
Participants
Start Date
February 28, 2005
Primary Completion Date
September 30, 2006
Study Completion Date
April 30, 2008
Dasatinib
Tablets; oral; 70 mg BID, depending on response
Local Institution, Anaheim
Local Institution, Loma Linda
Local Institution, Los Angeles
Local Institution, Stanford
Local Institution, Vallejo
Local Institution, Hartford
Local Institution, Washington D.C.
Local Institution, Jacksonville
Local Institution, Tampa
Local Institution, Atlanta
Local Institution, Chicago
Local Institution, Indianapolis
Local Institution, Kansas City
Local Institution, Baltimore
Local Institution, Boston
Local Institution, Detroit
Local Institution, Kansas City
Local Institution, St Louis
Local Institution, Omaha
Local Institution, Hackensack
Local Institution, New Brunswick
Local Institution, New York
Local Institution, Portland
Local Institution, Philadelphia
Local Institution, Pittsburgh
Local Institution, Greenville
Local Institution, Nashville
Local Institution, Dallas
Local Institution, Houston
Local Institution, San Antonio
Local Institution, Tyler
Local Institution, Spokane
Local Institution, St Leonards
Local Institution, South Brisbane
Local Institution, Adelaide
Local Institution, East Mebourne
Local Institution, Parkville
Local Institution, Wein
Local Institution, B-Leuven
Local Institution, Brussels
Local Institution, Edegem
Local Institution, Yvoir
Local Institution, Vancouver
Local Institution, Toronto
Local Institution, Montreal
Local Institution, Aarhus
Local Institution, Helsinki
Local Institution, Lille
Local Institution, Lyon
Local Institution, Nantes
Local Institution, Paris
Local Institution, Pessac
Local Institution, Poitiers
Local Institution, Strasbourg
Local Institution, Hamburg
Local Institution, Leipzig
Local Institution, Mainz
Local Institution, Mannheim
Local Institution, Co Galway
Local Institution, Dublin
Local Institution, Ramat Gan
Local Institution, Bari
Local Institution, Bologna
Local Institution, Milan
Local Institution, Napoli
Local Institution, Orbassano
Local Institution, Roma
Local Institution, Nijmegen
Local Institution, Rotterdam
Local Institution, Trondheim
Local Institution, Lima
Local Institution, Singapore
Local Institution, Parktown
Local Institution, Soweto
Local Institution, Kyunggi-Do
Local Institution, Barcelona
Local Institution, Madrid
Local Institution, Gothenburg
Local Institution, Lund
Local Institution, Stockholm
Local Institution, Umeå
Local Institution, Uppsala
Local Instituion, Basel
Local Institution, Glasgow
Local Institution, London
Lead Sponsor
Bristol-Myers Squibb
INDUSTRY